Neuroleptic dosage, duration, and tardive dyskinesia
Allen, R.E.; Stimmel, G.L.
Diseases of the Nervous System 38(5): 385-387
1977
ISSN/ISBN: 0012-3714 PMID: 852370 Document Number: 115910
Document emailed within 1 workday
Related Documents
Lohr, J.B.; Lohr, M.A.; Wasli, E.; Hilliard, B.; Larson, L.; Vardiman, E.; Wade, L.; Jeste, D.V. 1987: Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates Psychopharmacology Bulletin 23(1): 211-214Seeman, P.; Staiman, A.; Lee, T.; Chau-Wong, M. 1974: The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia Advances in Biochemical Psychopharmacology 9(0): 137-148
Gaillard-Sizaret, C.; Gaillard, P. 1979: Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials Therapie 34(5): 555-574
Driesens, F. 1988: Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. a critical review Acta Psychiatrica Belgica 88(3): 195-205
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Staton, R.D.; Brumback, R.A. 1980: Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis) Journal of Clinical Psychiatry 41(12 Part 1): 427-428
Reddi, K. 1985: Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to "tardive" dyskinesia independent of extent of neuroleptic medication Irish Medical Journal 78(9): 270
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Greenberg, D.B.; Murray, G.B. 1981: Hyperventilation as a variant of tardive dyskinesia Journal of Clinical Psychiatry 42(10): 401-403